help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on April 10, 2007
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-0176
A more recent version of this article appeared on July 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
92/7/2758    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jensen, R. B.
Right arrow Articles by Juul, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jensen, R. B.
Right arrow Articles by Juul, A.
Related Collections
Right arrow Neuroendocrinology and Pituitary
Right arrow Pediatric Endocrinology
Right arrow Metabolism

Submitted on January 24, 2007
Accepted on April 2, 2007

The presence of the d3-Growth Hormone (GH) Receptor Polymorphism is negatively associated with fetal growth but positively associated with postnatal growth in healthy subjects

Rikke Beck Jensen*, Signe Vielwerth, Torben Larsen, Gorm Greisen, Henrik Leffers, and Anders Juul

University Department of Growth and Reproduction, Rigshospitalet, Denmark, University Department of Neonatology, Rigshospitalet, Denmark, Department of Gynaecology and Obstetrics, Holbaek Sygehus, Sygehus Vestsjaelland, Denmark

* To whom correspondence should be addressed. E-mail: rikke.beck{at}rh.hosp.dk.

Context: A common polymorphism in the growth hormone receptor (GHR) gene has been linked to increased growth response in GH treated patients. No former study has focused on the association to prenatal growth.

Objective: To evaluate the association between the d3-GHR isoforms and spontaneous pre- and postnatal growth

Design: A prospective study on third trimester fetal growth velocity (FGV), birth weight (BW), birth length (BL) and postnatal growth

Setting: Copenhagen University Hospital

Participants: 115 healthy adolescents were divided into those born small for gestational age (SGA) and appropriate for gestational age (AGA) with or without intrauterine growth restriction (IUGR).

Main outcome measures: FGV measured by serial ultrasonography, BW, BL and adolescent height. Isoforms of the d3-GHR gene (fl/fl, d3/fl, d3/d3) were determined.

Results: The prevalence of the d3-GHR isoforms was 50%, but differed among the groups (p=0.006), in the SGA-IUGR group the prevalence was 88% and in SGA subjects carriers of the d3-GRH allele was associated with decreased third trimester FGV (P=0.05).

In the entire cohort carriers of the d3-GHR allele had a significantly increased height (-0.10 SDS vs. 0.34 SDS, P=0.017) and change in height from birth to adolescence compared to carriers of the fl-GHR allele (0.57 SDS vs. -0.02 SDS, P=0.005).

Conclusion: This study showed an increased spontaneous postnatal growth velocity in the carriers of the d3-GHR allele. Interestingly, we found the opposite effect on prenatal growth in the SGA group with a decreased fetal growth velocity in carriers of the d3-GHR allele.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society